7-甲基靛红 | 1127-59-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 7-甲基靛红
• 中文别名: 7-甲基-1H-吲哚-2,3-二酮
• 英文名称: 7-methyl-1H-indole-2,3-dione
• 英文别名: 7-methylisatin；7-methylindoline-2,3-dione；7-methylindole-2,3-dione；7-methyl-2,3-indolinedione
• CAS: 1127-59-9
• 化学式: C₉H₇NO₂
• mdl: MFCD00022797
• 分子量: 161.16
• InChiKey: UEHZKEABUOAZSH-UHFFFAOYSA-N

物化性质

• 熔点：
  212 °C
• 密度：
  1.301±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  46.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险品标志：
  Xi
• 危险性防范说明：
  P273,P305+P351+P338
• 危险性描述：
  H302,H319,H412
• 储存条件：
  存放于惰性气体中，以避免与空气接触。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 7-Methyl-1H-indole-2,3-dione
Synonyms: 7-Methylisatin

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 7-Methyl-1H-indole-2,3-dione
CAS number: 1127-59-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7NO2
Molecular weight: 161.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  7-甲基靛红 在 氨 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 5.0h， 以38%的产率得到2-氨基-3-甲基苯甲酰胺
  参考文献：
  名称：

  通过靛红的 C-C 键裂解可调谐邻氨基苯甲酸衍生物的电合成

  摘要：

  开发了一种简单直接的靛红电催化 C-C 键断裂/功能化反应。以靛红作为氨基连接的 C1 源，在温和条件下以中等至高产率合成了多种氨基苯甲酸酯和氨基苯甲酰胺。

  DOI：

  10.1021/acs.joc.1c01017
• 作为产物：
  描述：

  o-草酰甲苯胺 在 五氯化磷 、 硫酸 、 苯 作用下， 生成 7-甲基靛红
  参考文献：
  名称：

  Bauer, Chemische Berichte, 1907, vol. 40, p. 2653

  摘要：

  DOI：

文献信息

• Isatin <i>N</i>,<i>N</i>′-Cyclic Azomethine Imine 1,3-Dipole and Abnormal [3 + 2]-Cycloaddition with Maleimide in the Presence of 1,4-Diazabicyclo[2.2.2]octane
  作者：Xiao Wang、Peng Yang、Yong Zhang、Chao-Zhe Tang、Fang Tian、Lin Peng、Li-Xin Wang

  DOI：10.1021/acs.orglett.6b03815

  日期：2017.2.3

  A new isatin N,N′-cyclic azomethine imine synthon was devised, and an unexpected abnormal [3 + 2]-cycloaddition with maleimide catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO) has been disclosed. A variety of tricyclic spiropyrrolidine oxindoles bearing a dinitrogen heterocycle and succinimide scaffold were obtained in excellent yields (up to 96%) and diastereoselectivities (up to 97:3) under mild

  设计了一种新的Isatin N，N'-环甲亚胺亚胺合子，并公开了1,4-二氮杂双环[2.2.2]辛烷（DABCO）催化的马来酰亚胺意外异常[3 + 2]-环加成反应。在温和条件下，以优异的收率（高达96％）和非对映选择性（高达97：3）获得了多种带有二氮杂环和琥珀酰亚胺支架的三环螺吡咯烷恶唑。
• Process for producing 2-(carboxyphenyl)-4-quinolinecarboxylic acid
  申请人：The Green Cross Corporation

  公开号：US05780634A1

  公开（公告）日：1998-07-14

  Quinolin-2-yl benzoic acid compounds which are useful as intermediates of quinoline compounds having angiotensin II antagonist activity prepared by decarboxylating 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds in which a carboxyl group bonded to a phenyl group may be esterified, while a carboxyl group bonded to a quinoline ring is not esterified, and both rings may have one or more substituents inert to the decarboxylation reaction.

  喹啉-2-基苯甲酸化合物可作为血管紧张素II拮抗剂活性的喹啉化合物的中间体，通过脱羧2-(羧基苯基)-4-喹啉羧酸化合物制备，其中与苯基结合的羧基可酯化，而与喹啉环结合的羧基不酯化，两个环都可以有一个或多个对脱羧反应惰性的取代基。
• Synthesis and Biological Evaluation of Quinoline Salicylic Acids As P-Selectin Antagonists
  作者：Neelu Kaila、Kristin Janz、Silvano DeBernardo、Patricia W. Bedard、Raymond T. Camphausen、Steve Tam、Desirée H. H. Tsao、James C. Keith、Cheryl Nickerson-Nutter、Adam Shilling、Ruth Young-Sciame、Qin Wang

  DOI：10.1021/jm0602256

  日期：2007.1.1

  junctions into the underlying tissue. The initial rolling step is mediated by the interaction of leukocyte glycoproteins containing active moieties such as sialyl Lewisx (sLex) with P-selectin expressed on endothelial cells. Consequently, inhibition of this interaction by means of a small molecule P-selectin antagonist is an attractive strategy for the treatment of inflammatory diseases such as arthritis

  白细胞炎症和组织损伤部位的募集涉及白细胞沿内皮壁滚动，然后白细胞牢固粘附，最后白细胞跨细胞连接转运到下面的组织中。初始滚动步骤由包含活性部分的白细胞糖蛋白（如唾液酸化的Lewisx（sLex））与在内皮细胞上表达的P-选择蛋白的相互作用介导。因此，借助于小分子P-选择蛋白拮抗剂抑制这种相互作用是治疗炎性疾病如关节炎的有吸引力的策略。惠氏化学文库的高通量筛选确定了喹啉水杨酸类化合物（1）作为P-选择素的拮抗剂，其体外和基于细胞的测定方法的功效远远优于sLex。通过迭代药物化学，我们鉴定出具有改善的P-选择素活性，减少的二氢Orate脱氢酶抑制作用和可接受的CYP谱的类似物。铅化合物36在类风湿关节炎的大鼠AIA模型中有效。
• Methods and compositions for selectin inhibition
  申请人：Kaila Neelu

  公开号：US20050101568A1

  公开（公告）日：2005-05-12

  The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I: wherein the constituent variables are defined herein.

  本发明涉及抗炎物质领域，更特别地涉及作为哺乳动物粘附蛋白拮抗剂的新化合物。在某些实施例中，提供了治疗选择素介导疾病的方法，包括给予式I的化合物： 其中组分变量在此处定义。
• Combretastatin A-4 analogues with benzoxazolone scaffold: Synthesis, structure and biological activity
  作者：Mariana S. Gerova、Silviya R. Stateva、Elena M. Radonova、Rositsa B. Kalenderska、Rusi I. Rusew、Rositsa P. Nikolova、Christo D. Chanev、Boris L. Shivachev、Margarita D. Apostolova、Ognyan I. Petrov

  DOI：10.1016/j.ejmech.2016.05.012

  日期：2016.9

  analysis confirmed that 16Z induced cell cycle arrest in G2/M phase in the cell lines like combretastatin A-4. This arrest is followed by an abnormal exit of cells from mitosis without cytokinesis into a pseudo G1-like multinucleate state leading to late apoptosis and cell death. Accordingly, synthetic analogue 16Z was identified as the most promising potential anticancer agent in present study, and

  为了设计和合成一类新的天然康普他汀A-4杂环类似物及其合成衍生物AVE8062，选择了苯并恶唑酮环作为两个分子的B环生物立体替代的骨架。在Boden的条件下，通过改良的Wittig反应获得了28个顺式和反式-苯乙烯基苯并恶唑酮的文库。确定了在苯并恶唑酮核的4、5、6或7位上带有3,4,5-三甲氧基-，3,4-二甲氧基-，3,5-二甲氧基-和4-甲氧基苯乙烯基片段的新合成的化合物的结构根据光谱和X射线数据。在体外进行了检查针对不同的细胞系styrylbenzoxazolones的细胞毒性。二苯乙烯衍生物16 Z，（Z）-3-甲基-6-（3,4,5-三甲氧基苯乙烯基）-2（3 H）-苯并恶唑酮显示了该系列中最高的抗增殖潜力，对康普他汀耐药细胞株HT-的IC 50为0.25μM。 29，针对HepG2的0.19μM，针对EA.hy926的0.28μM和针对K562细胞的0.73μM。此外，流式细胞仪分析的结果证实了16